Simonetta Viviani

University of Siena

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (4)

Ilaria Manini

University of Siena

ITALY

View details

Emanuele Montomoli

University of Siena

ITALY

View details

Claudia M. Trombetta

University of Siena

ITALY

View details

Gianvito Lanave

University of Bari

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Simonetta Viviani

Research Interests

Explore related searches

Contact this professor

Articles (10)

Safety, reactogenicity, and immunogenicity of ZR-202-CoV and ZR-202a-CoV recombinant vaccines compared with ComirnatyⓇ: A randomized, observer-blind, controlled, phase 1 study

Evaluation of monkeypox‐ and vaccinia‐virus neutralizing antibodies before and after smallpox vaccination: A sero‐epidemiological study

Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children

Strengthening clinical development activities and preparedness for vaccine manufacturers from emerging countries: Results of a survey

Neutralizing activity of African lineage Zika virus immune sera towards Asian lineage

A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019?

SARS-CoV-2 Circulation during the First Year of the Pandemic: A Seroprevalence Study from January to December 2020 in Tuscany, Italy

Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines

Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination

Phase 1 Randomized, Placebo-Controlled, Dose-Escalating Study to Evaluate OVX836, a Nucleoprotein-Based Influenza Vaccine: Intramuscular Results

Collaborators (4)

Ilaria Manini

Emanuele Montomoli

Claudia M. Trombetta

Gianvito Lanave

Make your next move.